Get 50% OFF This Monsoon!

Advertisement
AdvertisementAdvertisement
logo

Genpharmasec

531592
Micro Cap
(%) 1D
no_data

No Data Available

1D1W1M3M6M1YMAX

Investor Sentiment

50%50%
Bullish
Bearish
Advertisement
AdvertisementAdvertisement

Genpharmasec Share price and Fundamental Analysis

View All Details
View All Details
Genpharmasec Limited was originally incorporated as Public Limited Company on 16th November, 1992 in the State of Gujarat as 'Adi Rasayan Limited'. The Company had received Certificate for Commencement of Business from ROC, Gujarat on November 20, 1992. Further, the name of Company was changed from 'Adi Rayasan Limited' to 'Genpharmasec Limited' on 27th November, 2018. Thereafter, the name of the Company was once again changed from Generic Pharmasec Limited' to ' Genpharmasec Limited' on 25th October, 2021 a fresh Certificate of Incorporation consequent upon the name change was obtained from the Registrar of Companies at Mumbai.
Company Incorporation1992
ChairmanNA
Head QuartersNA
Previous NameGeneric Pharmasec Ltd

Key Metrics

Market Cap (Cr)
113.51
PE Ratio
102.5
Industry P/E
45.18
PEG Ratio
-0.14
ROE
1.89%
ROCE
3.29%
ROA
1.93%
Total Debt (Cr)
3.44
Debt to Equity
0.08
Dividend Yield
0%
EPS
0.02
Book Value & P/B
1.2 x 1.71
Face Value
1
Outstanding Shares(Cr)
55.37
Current Ratio
3.02
EV to Sales
3.37

Stock Returns

1 Week-7.27%
1 Month-8.93%
6 Months-39.1%
1 Year+5.15%
3 Years-36.84%
5 Years-71.75%

CAGR

1 Year CAGR

Revenue Growth

+19.16%

Net Profit Growth

-115.05%

Operating Profit Growth

+96.5%

Dividend Growth

N/A

Stock Returns CAGR

+5.15%
no_data

No Stocks

Smart Score

1.4
icn

Unlock Smart Score

See Detailed Analysis & Insights

icn

Unlock Insights

See Detailed Analysis & Insights

Technicals

Returns Calculator

If you would have invested
In 5 years the current value would be
NaNCRNaNCR( %)

Research Report

No Research Report

View Other Reports >

Corporate Action

Board-Meetings
Board-Meetings
Dividends
Bonus
Splits
Right-issues
AGM-EGM
Bulk-Deal
Block-Deal

Financials

Half Yearly Statement

/ View Standalone
PARTICULARS

Total Revenue

Total Expenses

Operating Expense

Operating Profit

Interest

Depreciation & Amortization

Profit Before Tax

Tax

Profit after tax

Adj EPS in Rs - Basic

Adj EPS in Rs - Diluted

Profit and Loss Statement

/ View Standalone
Credit Rating
Director Report
Chairman Report
Auditor Report

Balance sheet

/ View Standalone

Cashflow Statement

/ View Standalone
Mar 25

Promoters : 29.98%

FIIs : 0.00%

DIIs : 0.00%

Public : 70.02%

Promoter
FII/FPI
DII
Public
Promoter Pledge stands at 0.0% of holding in March 2025 Qtr

Top Shareholders

View all Share Holders

Key Ratios

Profitability
Valuation
Liquidity

ROE

Avg ROE (3 Yrs) : NaN%

ROCE

Avg ROCE (3 Yrs) : NaN%

ROA

Avg ROA (3 Yrs) : NaN%

NPM

Avg NPM (3 Yrs) : NaN%

Dividend History

Genpharmasec Competitors

Sector
Industry

Company Name

MCap(TTM)

PE(TTM)

P/B(TTM)

ROE(TTM)

D/E

Current Ratio(TTM)

5 Year FactSheet

Profitability
Profitability
Growth Ratios
Valuation Ratios
Cashflow Ratios
Debt and Liquidity
Efficiency Ratios

Documents

Annual Reports
Con-Call

News

Genpharmasec Management and History

Company Management

icn

Unlock Management Data

See Detailed Analysis & Insights

Company History

Genpharmasec Limited was originally incorporated as Public Limited Company on 16th November, 1992 in the State of Gujarat as 'Adi Rasayan Limited'. The Company had received Certificate for Commencement of Business from ROC, Gujarat on November 20, 1992. Further, the name of Company was changed from 'Adi Rayasan Limited' to 'Genpharmasec Limited' on 27th November, 2018. Thereafter, the name of the Company was once again changed from Generic Pharmasec Limited' to ' Genpharmasec Limited' on 25th October, 2021 a fresh Certificate of Incorporation consequent upon the name change was obtained from the Registrar of Companies at Mumbai.

The company implemented a project to manufacture organic and inorganic chemicals, dyes and pigments, at Panoli, Gujarat. Initially, the Company started as a manufacturer and trader of organic and inorganic chemicals, dyes and pigments and from 2018 onwards, ity shifted business activities to buying, selling and distribution of all kinds of pharmaceutical, medicinal and medicated preparations and decided to venture into the securities market. In year 2019, the Company focused to the lucrative medical and diagnostics device segment. The Company tied up with Abbott Point of Care Corporation INC, USA for distribution of their niche diagnostic equipment namely, i-STAT 1 Analyzer which is a hand-held blood analyzer exclusively used in ICUs and ICCUs of hospitals for immediate test results.

Genpharmasec Share Price

Genpharmasec share price reflects investor sentiment toward the company and is impacted by various factors such as financial performance, market trends, and economic conditions. Share price is an indicator which shows the current value of the company's shares at which buyers or sellers can transact.

Genpharmasec Market Cap

Market capitalization of Genpharmasec indicates the total value of its outstanding shares. Marketcap is calculated by multiplying share price and outstanding shares of the company. It is a helpful metric for assessing the company's size and market Valuation. It also helps investors understand how Genpharmasec is valued compared to its competitors.

Genpharmasec PE Ratio

Genpharmasec PE ratio helps investors understand what is the market value of each stock compared to Genpharmasec 's earnings. A PE ratio higher than the average industry PE could indicate an overvaluation of the stock, whereas a lower PE compared to the average industry PE could indicate an undervaluation.

Genpharmasec PEG Ratio

The PEG ratio of Genpharmasec evaluates its PE ratio in relation to its growth rate. A PEG ratio of 1 indicates a fair value, a PEG ratio of less than 1 indicates undervaluation, and a PEG ratio of more than 1 indicates overvaluation.

Genpharmasec ROE (Return on Equity)

Return on Equity (ROE) measures how effectively Genpharmasec generates profit from shareholders' equity. A higher ROE of more than 20% indicates better financial performance in terms of profitability.

Genpharmasec ROCE (Return on Capital Employed)

Return on Capital Employed (ROCE) evaluates the profitability of Genpharmasec in relation to its capital employed. In simple terms, ROCE provides insight to investors as to how well the company is utilizing the capital deployed. A high ROCE of more than 20% shows that the business is making profitable use of its capital.

Genpharmasec Total Debt

Total debt of Genpharmasec shows how much the company owes to either banks or individual creditors. In simple terms, this is the amount the company has to repay. Total debt can be a very useful metric to show the financial health of the company. Total debt more than equity is considered to be a bad sign.

Genpharmasec Debt to Equity Ratio

The Debt-to-Equity (DE) ratio of Genpharmasec compares its total debt to shareholders' equity. A higher Debt to Equity ratio could indicate higher financial risk, while a lower ratio suggests that the company is managing its debt efficiently.

Genpharmasec CAGR (Compound Annual Growth Rate)

CAGR shows the consistent growth rate of Genpharmasec over a specific period, whether it is over a month, a year, or 10 years. It is a key metric to evaluate the company’s long-term growth potential. Main metrics for which CAGR is calculated are net sales, net profit, operating profit, and stock returns.

Genpharmasec Technical Analysis

Technical analysis of Genpharmasec helps investors get an insight into when they can enter or exit the stock. Key components of Genpharmasec Technical Analysis include:

Support Levels (S1, S2, S3)

There are usually multiple support levels, but the main support levels for a stock are S1, S2, S3. Support levels indicate price points where stock might get support from buyers, helping the stock stop falling and rise.

Resistance Levels (R1, R2, R3)

There are usually multiple resistance levels, but the main resistance levels for a stock are R1, R2, R3. Resistance levels represent price points where Genpharmasec shares often struggle to rise above due to selling pressure.

Genpharmasec Dividends

Dividends refer to the portion of the company’s profits distributed to its shareholders. Dividends are typically paid out in cash and reflect Genpharmasec ’s financial health and profitability.

Genpharmasec Bonus Shares

Bonus shares are usually given by companies to make the stock more affordable, increase liquidity, boost investor confidence, and more.

Genpharmasec Stock Split

Stock split increases the number of its outstanding shares by dividing each existing share into multiple shares. When the company offers a stock split, the face value of the stock reduces in the same proportion as the split ratio.

Genpharmasec Financials

The financials of Genpharmasec provide a complete view to investors about its net sales, net profit, operating profits, expenses, and overall financial health. Investors can analyze financial data to assess the company’s stability and also understand how the company has been growing financially.

Genpharmasec Profit and Loss Statements

The profit and loss statement of Genpharmasec highlights its net sales, net profit, total expenditure, and operating profits in the current financial year. This Profit and Loss statement is crucial for evaluating the profitability and financial stability of Genpharmasec .

Genpharmasec Balance Sheet

The balance sheet presents a snapshot of Genpharmasec ’s assets, liabilities, and equity of shareholders, providing insights into the financials of the company.

Genpharmasec Cashflow Statements

Cashflow statements track the company's cash inflows and outflows over a period. It is an essential tool for understanding how well the company manages its liquidity and finances.

Download the App

Download the App